Company Name	Biogen Inc.
Drug Name	Aducanumab (BLA)
Event Name	FDA decision on Aducanumab for Alzheimer's Disease
Event Date	03/07/2021
Outcome Date
Outcome
Drug Status	Priority Review
Rival Drugs
Market Potential
Other Approvals
News

Return to FDA Calendar